Introduction
In mammals, the sperm activates the egg by triggering longlasting Ca 2+ oscillations in egg cytoplasm (Cuthbertson and Cobbold, 1985; Kline and Kline, 1992; Sun et al., 1992; Miyazaki et al., 1993; Schultz and Kopf, 1995; Swann and Lai, 1997) . Accumulated evidence suggests that the sperminduced Ca 2+ oscillations are triggered by a sperm-derived protein factor which diffuses into the egg cytoplasm after gamete membrane fusion (Swann, 1990; Swann and Lai, 1997) . The activity of this sperm factor in triggering Ca 2+ oscillations in mammalian eggs appears to be highly conserved during evolution Li et al., 2001) . Although the sperm factor has not yet been biochemically purified, recent studies have shown that phospholipase C (PLC)ζ appears to be a strong candidate for the mammalian sperm factor (Saunders et al., 2002; Kouchi et al., 2004) .
The sperm factor mobilizes Ca 2+ release from the egg's intracellular stores (Swann, 1994) mainly through inositol trisphosphate (InsP3) receptors because blocking the function of the InsP3 receptors completely inhibited sperm-induced Ca 2+ release (Miyazaki et al., 1992 (Miyazaki et al., , 1993 . Maintenance of the sperm factor-induced Ca 2+ oscillations at fertilization requires Ca 2+ influx (Swann, 1994) , and is critically dependent upon the presence of a functional maternal machinery . The sperm-induced Ca 2+ oscillations are spatially organized as propagating waves (Miyazaki et al., 1992) , last for several hours and cease at about the time of pronuclear formation Kono et al., 1996) . The first Ca 2+ transient, and some subsequent increases in Ca 2+ , are essential for egg activation (Kline and Kline, 1992) , while later long-lasting Ca 2+ oscillations facilitate early embryonic development such as pronuclear formation (Swann and Ozil, 1994; Ducibella et al., 2002) .
Mammalian egg activation can also be achieved by a variety of artificial stimuli (Swann and Ozil, 1994) . Sr 2+ has been shown as the most efficient parthenogenetic agent for activating mouse ovulated eggs (Kline and Kline, 1992; Bos-Mikich et al., 1997) and nuclear-transplanted eggs (Wakayama et al., 1998) . In addition, Sr 2+ -induced Ca 2+ transients were also observed in activated eggs (Kono et al., 1996) . Extending the exposure time to Sr 2+ -containing medium during egg activation and the first mitosis promoted preimplantation development (Bos-Mikich et al., 1997) . However, so far, the mechanism by which Sr 2+ induces Ca 2+ oscillations in mammalian oocytes and early embryos remains unknown. In the present study, we examined the specificity and possible mechanism of Sr 2+ -induced Ca 2+ oscillations in mouse meiotic oocytes and early embryos. Our results show that Sr 2+ -induced Ca 2+ oscillations in mouse meiotic oocytes and early embryos are mediated through the InsP3 receptors, and require PLC activation and a synergistic action of InsP3.
Materials and methods
Unless otherwise stated, all chemicals used in this study were purchased from Sigma chemicals (St. Louis, MO, USA). U73122 and U73343 were from CALBIOCHEM (EMD Biosciences Inc. La Jolla, USA).
Preparation of mouse oocytes, zygotes and parthenogenetic (PG) embryos
For collection of germinal vesicle (GV) oocytes, the ovaries were removed from Kunming Abiro female mice (bred in the Institute of Genetics and Developmental Biology) 46-48 h after injection of pregnant mare serum gonadotrophin (PMSG). Antral follicles were punctured by 30 gauge needles, and cumulus-enclosed GV oocytes were released into M2 medium with 4 mg/ml bovine serum albumin (BSA fraction V, Sigma) (Fulton and Whittingham, 1978) containing 0.2 mM 3-isobutyl-1-methylxanthine (IBMX) to inhibit germinal vesicle breakdown (GVBD). Metaphase I (MI) oocytes were collected from oocytes cultured for 6-7 h from GV oocytes. MII eggs were collected from 4-to 6-week-old female Kunming Abiro mice as described previously . Female Kunming Abiro mice were superovulated by serial injection of PMSG and HCG 48 h apart. MII oocytes were collected from the oviducts at 14-16 h post-HCG into pre-warmed M2 medium supplemented with 4 mg/ml BSA. The cumulus cells were removed by a brief incubation at 37°C in hyaluronidase (0.3 mg/ml, Sigma) in M2 + BSA. The MII oocytes were then washed three times in M2 + BSA and transferred to microdrops of M2 + BSA under paraffin oil pending further treatments.
To obtain fertilized eggs (zygotes) at different cell cycle stages, female mice were paired with males immediately following HCG injection. S-and M-phase zygotes were subsequently collected at 23-24 and 30 h post-HCG, respectively. It should be noted here that, in our study, the M-phase zygotes refer to those fertilized eggs that had already undergone complete nuclear membrane breakdown. PG embryos were produced by exposure of MII oocytes at 17-18 h post-HCG to 7% ethanol in M2 medium for 7 min at room temperature. The oocytes were then washed three times with M2 + BSA, and cultured in KSOM medium (Lawitts and Biggers, 1993) at 37°C, 5% CO 2 in air. To produce diploid PG embryos, the MII oocytes were treated with cytochalasin B (5 µg/ml) for ∼6 h immediately after the activation treatment. S-phase PG 1-cell embryos were obtained at 10-12 h after ethanol activation, while M-phase PG embryos were subsequently obtained at 18-20 h for the ethanol-activated group or at 16-18 h for the Sr 2+ -activated group.
Microinjection of MII oocytes, zygotes and PG 1-cell embryos
Micromanipulation of mouse MII oocytes and 1-cell embryos was conducted following the procedures described by Tang et al. (2000) . All injections were carried out using a pair of manually operated pressure microinjectors (IM-6, Narishige, Japan) filled with paraffin oil. Microinjection pipettes (Clark Electromedical Instruments, UK) were pulled by a micropipette puller (Sutter Instrument company, Model P-87, USA) to give an open tip (inner diameter 1-2 µm) and a long taper of ∼10 mm in length. The microinjection pipette was connected to the microinjector and then filled with paraffin oil. Microinjection of heparin and injection volume were measured as described by Tang et al. (2000) . In addition, the procedures for bovine sperm extract preparation and injection were the same as described previously .
Intracellular Ca 2+ measurements
Before intracellular Ca 2+ concentration ([Ca 2+ ]i) measurement, mouse oocytes or zygotes were loaded with 2 µM Fura-2 AM (Molecular Probes) in M2 medium containing 4 mg/ml BSA at 37°C for 30 min. After loading, the cells were washed three times in M2 and then transferred to a chamber containing M2 medium covered by light paraffin oil. The procedures and equipment used for calcium measurement were the same as described by Dong et al. (2000) . The emitted fluorescence intensities at 510 nm were recorded at 340 and 380 nm excitation wavelengths by a Mira-1000TE low light level CCD camera. The fluorescence signal is displayed as the ratio of fluorescence intensities for the 340 nm/380 nm excitation wavelengths. [Ca 2+ ]i was estimated from the ratio equation described by Grynkiewicz et al. (1985) , which is calculated by computer simultaneously. The intensity of excitation UV light was reduced by neutral density filters. Parameters required for the ratio equation were obtained according to the method of Poenie et al. (1985) . [Ca 2+ ]i were recorded immediately after the initial exposure of the oocytes to Sr 2+ . The [Ca 2+ ]i image was recorded every 2 s for up to 2-4 h.
Results

Sr 2+ induces Ca 2+ oscillations in immature and mature oocytes
The Ca 2+ responses to Sr 2+ in mouse immature and mature oocytes are illustrated in Figure 1 . GV oocytes can exhibit spontaneous Ca 2+ oscillations (Carroll and Swann, 1992) ; we therefore used IBMX (50 µg/ml for 3 h) to block (GVBD), and treated GV oocytes with Sr 2+ only after their spontaneous Ca 2+ oscillations had completely ceased. Table I shows that addition of 20 mM Sr 2+ induces GV, MI and MII oocytes to produce a series of Ca 2+ oscillations. In comparison with mature oocytes, immature oocytes (GV and MI) exhibited a lower amplitude and a shorter spiking interval. In general, the first Ca 2+ transient in MII oocytes induced by Sr 2+ was broader and had a larger amplitude than the subsequent spikes. In both immature and mature oocytes, the characteristics of the spikes in the same oocytes induced by 20 mM Sr 2+ were remarkably similar. In all cases, the rate of increase of Ca 2+ was always faster than the rate of recovery.
Sr 2+ -induced Ca 2+ oscillations in 1-cell embryos are cell cycle stage dependent
To investigate whether Sr 2+ can induce Ca 2+ oscillations at any cell cycle stages in mouse early embryos, and whether Sr 2+induced Ca 2+ oscillations in embryos are fertilization status dependent, we treated embryos derived from both fertilized and PG embryos with 20 mM Sr 2+ at different cell cycle stages and then examined their responses to the treatment. Figure 2 shows the patterns of Ca 2+ signalling in embryos. Characteristics Table I . Sr 2+ can induce Ca 2+ oscillations in interphase 1-cell embryos in a manner independent of their fertilization status. However, at metaphase, none of the embryos derived from the fertilized or the PG eggs was sensitive to Sr 2+ , indicating that the ability of Sr 2+ to trigger intracellular Ca 2+ release in embryos is cell cycle stage dependent. In addition, when interphase 2-cell embryos were treated with 20 mM Sr 2+ , Ca 2+ oscillations also occurred in the embryos in a manner independent of their fertilization status. Clearly, our finding is not consistent with that reported previously (Kono et al., 1996; Bos-Mikich et al., 1997) . To examine whether the lack of calcium oscillations is due to embryo quality or a possible toxic effect of Sr 2+ at 20 mM on the metaphase 1-cell embryos, we first tested whether reducing the Sr 2+ concentration to 10 mM could induce an increase in Ca 2+ in the PG embryos. It is found that all metaphase PG embryos (n = 27) treated with 10 mM Sr 2+ failed to generate any Ca 2+ oscillations during 2 h of detection. We then examined whether the metaphase PG embryos that failed to respond to 20 mM Sr 2+ could generate sperm factor-induced Ca 2+ oscillations. Figure 3 shows that injection of a physiological dose of the sperm extract had caused the Sr 2+stimulated PG embryos to generate Ca 2+ oscillations (nine out of 12 embryos examined) in M2 medium containing Ca 2+ , in a manner similar to our previous finding . Moreover, it was found that low frequency oscillatory increases of Ca 2+ even occurred in the sperm extract-injected metaphase embryos (eight out of 11) in M2 medium with 20 mM Sr 2+ . Our results therefore suggest that there is indeed a striking difference in the ability of Sr 2+ and sperm protein factor in triggering Ca 2+ oscillations in the M-phase 1-cell PG embryos.
Sr 2+ -induced Ca 2+ oscillations in MII oocytes and embryos are mediated through the InsP3 receptors
InsP3 receptors play an essential role in determining Ca 2+ oscillations at fertilization (Miyazaki et al., 1992 (Miyazaki et al., , 1993 . Heparin, as an effective InsP3 receptor antagonist, has been widely used to determine the role of InsP3 receptors in regulating intracellular Ca 2+ release (Rakow and Shen, 1990; Carroll and Swann, 1992) . Here, we used a low molecular weight heparin to examine whether InsP3 receptors are critical in regulating Sr 2+ -induced Ca 2+ oscillations in mouse oocytes and interphase embryos. In doing so, we firstly injected various concentrations of InsP3 into MII oocytes and established the minimal intracellular dosage of InsP3 required for inducing calcium oscillations. As shown in Figure 4 , when the intracellular concentration of injected InsP3 is 100 nM, oscillatory increases in Ca 2+ occurred in the oocytes, and the amplitude of the Ca 2+ increases appears to be InsP3 dosage dependent. This is consistent with the finding of a previous report . We then tested the effect of heparin at different concentrations on InsP3-induced Ca 2+ oscillations in the oocytes. It is found that when the intracellular concentration of heparin is 120 µM, it completely inhibited the increases in Ca 2+ induced by 100 nM InsP3. The effect of various concentrations of heparin on Sr 2+ -induced Ca 2+ oscillations in MII oocytes and 1-cell PG embryos is shown in Table II . In 1-cell PG embryos, Sr 2+ -induced intracellular increases in Ca 2+ were effectively inhibited even at an intracellular concentration of 10-60 µM heparin (n = 13). To confirm further the inhibitory effect of heparin on Sr 2+ -induced Ca 2+ release, we then tested whether injecting MII oocytes with 120 µM heparin could block Sr 2+ -induced egg activation. It is found that none of the heparin-injected oocytes (n = 39) following 2 h treatment with 20 mM Sr 2+ had formed a pronucleus at 8 h after the treatment. However, when the injected oocytes were stimulated with 10 µg/ml cycloheximide, >50% of the them (18 out of 33 examined) had been activated, evidenced by the presence of a female pronucleus following 8 h of incubation. This is consistent with the finding that cycloheximide as a protein synthesis inhibitor could activate mouse eggs in a manner independent of their intracellular Ca 2+ increase (Bos-Mikich et al., 1995) . In conclusion, our results therefore suggest that InsP3 receptors are essential in mediating the Sr 2+ -induced increase in intracellular Ca 2+ in mouse MII oocytes and 1-cell embryos.
Sr 2+ -induced Ca 2+ oscillations in mouse oocytes require activation of PLC
U73122 is a membrane-permeable inhibitor of PLC (Bleasdale et al., 1990; Yule and Williams, 1992) , and has been used to determine PLC activation of Ca 2+ oscillations induced by sperm or sperm protein factor (Dupont et al., 1996) . Here, U73122 was used to examine whether Sr 2+ -induced Ca 2+ oscillations in mouse oocytes require activation of PLC. As a control experiment, we first tested the effect of U73122 and U73343 on acetylcholine (Ach)-induced increases in Ca 2+ in mouse oocytes. Ach-induced increases in Ca 2+ in mouse oocytes were mediated by activating PLC (Dupont et al., 1996) . We found that 40 µM U73122 could effectively block the increase in Ca 2+ induced by 50 µM Ach in the oocytes (data no shown here). Pre-incubating MII oocytes with U73122 at an intracellular concentration of 1-30 µM for 30 min before treatment with Sr 2+ caused a dose-dependent inhibition of Ca 2+ oscillations induced by Sr 2+ (Figure 5 ). When U73122 was at a concentration of 10 µM, <40% of treated oocytes (eight out of 21 examined) showed Sr 2+ -induced Ca 2+ oscillations. However, when increasing the U73122 concentration to 20 µM, Sr 2+ -induced Ca 2+ oscillations were completely inhibited in all oocytes treated (n = 13). On the contrary, pre-incubating oocytes with U73343, an inactive analogue of the PLC inhibitor U73122, had no effect on Sr 2+ -induced Ca 2+ oscillations even at a concentration of 30 µM (n = 12). These results indicate that activation of PLC to generate InsP3 is required for Sr 2+ -induced Ca 2+ oscillation in mouse oocytes.
Sr 2+ -induced Ca 2+ oscillations in mouse oocytes require a synergistic action of InsP3
To determine the relationship between InsP3 and Sr 2+ on Sr 2+ -induced Ca 2+ oscillations in mouse eggs, we tested whether injection of a physiological concentration of InsP3 could rescue the inhibitory effect of U73122 on Sr 2+ -induced Ca 2+ oscillations. Figure 6 shows that in the presence of 20 µM U73122, injection of 100 nM InsP3 induced only 1-2 spikes (seven out of seven), while addition of 20 mM Sr 2+ caused the InsP3injected eggs to generate Ca 2+ oscillations (seven out of 10). These observations suggest that there is asynergistic action of InsP3 in determining Sr 2+ -induced Ca 2+ oscillations in mouse oocytes.
Discussion
The present study investigated the possible mechanism by which Sr 2+ promotes intracellular Ca 2+ release in mouse oocytes and early embryos. Our major findings are: (i) Sr 2+ can induce Ca 2+ oscillations in both immature and mature oocytes as well as in early embryos, and its effect on 1-cell embryos is cell cycle stage dependent; (ii) Sr 2+ -induced calcium oscillations in meiotic oocytes and embryos are mediated through the InsP3 receptors; and (iii) Sr 2+ -induced Ca 2+ oscillations in mouse oocytes require activation of PLC and the synergistic action of InsP3. To our knowledge, this is the first report showing how Sr 2+ promotes intracellular Ca 2+ release in mouse oocytes and early embryos.
The mechanism underlying the maintenance of Ca 2+ oscillations induced by Sr 2+ and sperm is different
It has been demonstrated in the mouse that sperm-induced calcium oscillations at fertilization are mediated by the InsP3 receptors (Miyazaki et al., 1992 (Miyazaki et al., , 1993 . The results of the present study show that Sr 2+ can induce calcium oscillations in mouse oocytes and embryos in calcium-free medium and that antagonizing the function of InsP3 receptors by low molecular weight heparin blocked Sr 2+ -induced calcium oscillations, indicating that calcium oscillations induced by Sr 2+ are also regulated through the InsP3 receptors. In an early study, it had been demonstrated that the persistence of the sperm factorinduced calcium oscillations requires a putative maternal machinery, which functions only once and is abolished in the zygotes . The results of the present study show that Sr 2+ can induce Ca 2+ oscillations not only in meiotic oocytes but also in early embryos derived from fertilized eggs, suggesting that the persistence of the long-lasting calcium oscillations induced by Sr 2+ in both mouse oocytes and embryos does not require this putative maternal machinery. We therefore conclude that although sperm protein factor-and Sr 2+ -induced Ca 2+ oscillations are both mediated through the InsP3 receptors, different mechanisms exist with regard to their requirement for a functional maternal machinery in determining the persistence of Ca 2+ oscillations.
Action of Sr 2+ in promoting intracellular Ca 2+ release
Ca 2+ signalling in mouse oocytes can be affected by the amount of releasable Ca 2+ in the intracellular stores , the number of intact InsP3-1 receptors (InsP3R-1s) and the sensitivity status of InsP3R-1 to InsP3 (Jellerette et al., 2004) . Although it is difficult to measure the precise amount of intracellular InsP3 required for its effect on Sr 2+ -induced Ca 2+ oscillations in mouse eggs, the results in this study show that activation of PLC to generate InsP3 is required for Sr 2+ -induced Ca 2+ signalling. Mouse eggs will generate Ca 2+ oscillations in Ca 2+ -containing medium either when stimulated with agonists that activate G-protein or PLC to generate InsP3 (Jaffe, 1990) or when injected with InsP3 Tang et al., 2000) . The findings that treatment with U73122 blocked Sr 2+ -induced Ca 2+ oscillations while microinjection of InsP3 to increase intracellular InsP3 promoted longlasting Ca 2+ oscillations imply a synergistic action of InsP3 on Sr 2+ -induced Ca 2+ oscillation. It has been suggested that Sr 2+ can improve the sensitivity of InsP3R. Hamada et al. (2003) have shown, by applying electron microscopy and proteolytic analyses, the conformational changes of InsP3R-1 bound by bivalent ions (Ca 2+ , Sr 2+ , Ba 2+ and Mg 2+ ). It was shown that the Ca 2+ -specific conformational change can structurally affect the InsP3-triggered channel opening within InsP3R-1. It has also been shown that Sr 2+ can trigger fast exocytosis by binding to the Ca 2+ -binding site of the synaptotagmin 1 C2B domain of InsP3R-1 (Shin et al., 2003) . In addition, it is reported that at least two Ca 2+ interaction sites should exist in InsP3R-1: a stimulatory site sensitive to Sr 2+ and an inhibitory site insensitive to Sr 2+ (Marshall and Taylor, 1994; Xu et al., 2003) . In another study using sheep cerebellum microsomes (Worley et al., 1987) , measurements of [ 3 H]InsP3 binding at a low concentration showed that Sr 2+ and Ca 2+ did not enhance the amount of bound [ 3 H]InsP3, implying that the activating effect of Sr 2+ and Ca 2+ in cerebellar microsomes is mediated by an increase in the channel opening probability and not by increasing the receptor's affinity for InsP3. Based on these findings, together with our observation ( Figure 5 ), we speculate that Sr 2+ promotes Ca 2+ oscillations in mouse oocytes and embryos probably by sensitizing the InsP3 receptors (the Ca 2+ release channels) to release Ca 2+ . However, we still do not know how Sr 2+ affects PLC activation to generate InsP3 and how in Ca 2+ -free medium the Sr 2+ -induced Ca 2+ oscillations can persist for several hours. One possibility is that Sr 2+ acts as a surrogate for Ca 2+ , such that Sr 2+ -induced Ca 2+ oscillations in Ca 2+ -free medium reflect changes in the fura ratio in response to changing [Sr 2+ ]i, but direct evidence to support this possibility is at present still lacking.
Sr 2+ -induced Ca 2+ oscillations in early embryos are cell cycle stage dependent
The present study reveals two striking differences between the sperm protein factor and Sr 2+ in regulating Ca 2+ release in early embryos. First, at interphase of the first mitosis, neither fertilized nor PG embryos were able to generate Ca 2+ oscillations upon sperm factor injection ; however, both types of embryos at interphase exhibit Ca 2+ oscillations when treated by Sr 2+ . Secondly, at metaphase of the first mitosis, the sperm protein factor can cause PG embryos to undergo Ca 2+ oscillations, while Sr 2+ cannot. These findings indicate that although at the same cell cycle stage and with theoretically an identical cellular environment, the response of the cells to the stimulation of these two oscillatory Ca 2+ stimuli is strikingly different. In theory, since the embryos were generated by the same approach and at the same cell cycle stage, it is most likely that the difference is attributed to the stimulation of Sr 2+ and sperm protein factor. There is evidence showing that phosphorylation can modify the function or conductivity of InsP3R Krizanova and Ondrias, 2004) and that phosphorylation of InsP3R-1 occurs at interphase of the first mitosis (Jellerette et al., 2004) . We consider that the phenomenon of cell cycle stage dependency of Sr 2+ and sperm protein factors in triggering Ca 2+ oscillations in embryos reflects the basic difference in the mechanisms underlying how Ca 2+ release is triggered by Sr 2+ and the sperm factor. In the present study, we show that Sr 2+ can induce the 1-cell embryos to undergo Ca 2+ oscillations, in a manner independent of their fertilization status, in interphase but not M phase. This finding is clearly contrary to two previous reports that Sr 2+ triggers Ca 2+ oscillations in M phase, but not interphase (Kono et al., 1996; Bos-Mikich et al., 1997) . We have shown that this difference is not due to the concentrations of Sr 2+ used, because even using the same concentration (10 mM) as that described in the two previous reports, we still failed to detect any Ca 2+ oscillations in the M-phase embryos. In addition, we show that the M-phase embryos that failed to generate Sr 2+ -induced Ca 2+ oscillations were able to do so when injected with a physiological dosage of the sperm extract (Figure 3 ), suggesting a striking difference between the sperm factor and Sr 2+ in inducing Ca 2+ oscillations in M-phase 1-cell PG embryos. It should be noted here that the strain of mouse used in our study is different from that used in the previous reports (Kono et al., 1996; Bos-Mikich et al., 1997) . This may be the reason for the striking difference between our finding and that of the two previous reports, but the molecular basis for this variation is still a mystery. The present study has shown that PLC activation is required for Sr 2+ -induced Ca 2+ oscillations, and that Sr 2+ need a synergistic activation of InsP3 to generate Ca 2+ oscillations. Our findings imply that the activation of PLC may be important for maintaining a basal intracellular InsP3 concentration required for the synergistic action. This possibility is supported by our finding ( Figure 6 ) that injecting InsP3 into U73122treated eggs reinitiated Ca 2+ oscillations in Sr 2+ -containing medium, while without Sr 2+ the same group of eggs generated only 1-2 spikes. The combined findings point to the possibility that the dominant action of Sr 2+ in triggering intracellular Ca 2+ release is mediated by stimulating intracellular Ca 2+ channels, probably by inducing a conformational change in InsP3 receptors (Hamada et al., 2003) .
Impact of Ca 2+ signalling on embryonic development
Sr 2+ has been proved to be the most efficient agent for activating mouse eggs (Kline and Kline, 1992; Bos-Mikich et al., 1997) . This is probably due to its ability to trigger fertilizationlike Ca 2+ oscillations in the egg cytoplasm. In all mammals studied so far, the sperm activates the egg by causing longlasting Ca 2+ oscillations (see the review by Stricker, 1999) . Similarly, human eggs at fertilization also exhibited Ca 2+ oscillations (Taylor et al., 1992) .
Ca 2+ signalling at fertilization is a vital event for switching the oocytes from meiosis to mitosis (Swann and Ozil, 1994; Ducibella et al., 2002) . Ca 2+ transients can affect morphological, by guest on November 8, 2016 http://humrep.oxfordjournals.org/ Downloaded from biochemical and developmental events of egg activation. Moreover, extending the exposure time to Sr 2+ -containing medium during egg activation and the first mitosis promoted preimplantation development in the mouse (Bos-Mikich et al., 1997) . Manipulating Ca 2+ signalling patterns during egg activation can severely alter mammalian preimplantation development and implantation outcome (Ozil and Huneau, 2001) . In addition, it has been shown that the Ca 2+ signal controls chromosome disjunction in early sea urchin embryos (Groigno and Whitaker, 1998) . Altering Ca 2+ signalling in mammalian cells affects the metaphase-anaphase transition by interfering with the spindle checkpoint (Xu et al, 2003) . Our findings that Sr 2+ can promote Ca 2+ oscillations in immature and mature oocytes, and early embryos, and that the action of Sr 2+ involves activation of PLC and a synergetic action of InsP3 illustrates that Sr 2+ can be used as a physiological agent to dissect the effect of Ca 2+ oscillatory signals on nuclear and cytoplasmic events of mammalian oocyte maturation, gene expression and developmental events associated with preimplantation and implantation. It will be extremely interesting and worthwhile to find out in future studies how Ca 2+ signals upon egg activation could alter preimplantation development and implantation outcome, and whether improved embryo quality and implantation outcome can be achieved by providing the human eggs with adequate Ca 2+ signals at fertilization.
